4.7 Article

Statins as Potential Preventative Treatment of ETX and Multiple Pore-Forming Toxin-Induced Diseases

期刊

出版社

MDPI
DOI: 10.3390/ijms24065414

关键词

statins; Clostridium perfringens epsilon-toxin; Zaragozic acid; therapy; pore-formation

向作者/读者索取更多资源

This study found that Zaragozic acid (ZA) significantly reduced the toxicity of Epsilon toxin (ETX) in cells. ZA did not affect the binding of ETX to cells, but disrupted the ability of ETX to form pores or oligomers, reducing its harm to cells. Additionally, ZA decreased phosphatidylserine exposure and increased calcium influx in cells. ZA also protected mice from ETX in vivo, suggesting its potential as a broad-spectrum medicine for multiple toxin-induced diseases.
Epsilon toxin (ETX), produced by type B and D strains of Clostridium perfringens, can cause fatal enterotoxaemia in ruminant animals, particularly sheep, cattle, and goats. Previous studies show that the cytotoxicity of ETX is dependent on the integrity of lipid rafts, the maintenance of which is ensured by cholesterol. Zaragozic acid (ZA) is a statin drug that reduces the synthesis of squalene, which is responsible for cholesterol synthesis. In this study, ZA significantly reduced the toxicity of ETX in Madin-Darby canine kidney (MDCK) cells. We show that ZA does not affect the binding of ETX to MDCK cells, but propidium iodide staining (PI) and Western blotting confirmed that ZA significantly disrupts the ability of ETX to form pores or oligomers in MDCK cells. Additionally, ZA decreased the phosphatidylserine exposure on the plasma membrane and increased the Ca2+ influx of the cells. Results of density gradient centrifugation suggest that ZA decreased the number of lipid rafts in MDCK membranes, which probably contributed to the attenuation of pore-formation. Moreover, ZA protected mice against ETX in vivo. All mice pre-treated with ZA for 48 h before exposure to an absolute lethal dose of ETX (6400 ng/kg) survived. In summary, these findings provide an innovative method to prevent ETX intoxication. Considering many pore-forming toxins require lipid rafts, we tested and found ZA also inhibited the toxicity of other toxins such as Clostridium perfringens Net B and beta-toxin (CPB) and Staphylococcus aureus alpha-hemolysin (Hla). We expect ZA can thus be developed as a broad-spectrum medicine for the treatment of multiple toxins. In addition, other statins, such as lovastatin (LO), also reduced the toxicity of ETX. These findings indicate that statin medicines are potential candidates for preventing and treating multiple toxin-induced diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据